SCHEMBL4362603

SCHEMBL4362603

CCOc1nc2c(C)ccnc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.42
GRM5 P41594 1/20 0.38
SYK P43405 1/20 0.35
ELANE P08246 1/20 0.35
CCR1 P32246 1/20 0.33
CCR5 P51681 1/20 0.33
CCR8 P51685 1/20 0.33
LRRK2 Q5S007 1/20 0.33
NUDT1 P36639 1/20 0.33
CDK5 Q00535 3/20 0.33
CDK5R1 Q15078 3/20 0.33
CDK2 P24941 2/20 0.33
CCNB2 O95067 2/20 0.33
CDK1 P06493 2/20 0.33
CCNB1 P14635 2/20 0.33
GSK3A P49840 2/20 0.33
GSK3B P49841 2/20 0.33
CCNB3 Q8WWL7 2/20 0.33
CCNE1 P24864 1/20 0.33
ZAP70 P43403 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4365192 0.82 KDM4C (0.41) KDM4CSYKCDK5CDK5R1CDK2
SCHEMBL1665498 0.78 PARP1 (0.42) CCR1CCR5CCR8CDK5CDK5R1
SCHEMBL4360864 0.77 MAPT (0.37) KDM4CMEN1KMT2AL3MBTL1HCAR2
SCHEMBL4370028 0.76 ADORA1 (0.41) CCR1CCR5CCR8LRRK2CDK2
SCHEMBL4365099 0.75 CBFB (0.49)
SCHEMBL4370037 0.73 NOS2 (0.41) KDM4CCCR1CCR5CCR8CDK5
SCHEMBL3948888 0.72 ADORA3 (0.34) CCR1CCR5CCR8LRRK2CDK5
SCHEMBL9310095 0.72 ALDH1A1 (0.41) KDM4C
SCHEMBL21620456 0.72 CCNB2 (0.40) CCR1CCR5CCR8CDK5CDK5R1
SCHEMBL21620891 0.72 NOS3 (0.41) CCR1CCR5CCR8CDK5CDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1988091-B1 TRICYCLIC COMPOUNDS KYOWA HAKKO KIRIN CO LTD (JP) 2015-06-10 EP disclosed
US-8242151-B2 Tricyclic compounds KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-08-14 US disclosed
US-20090176760-A1 TRICYCLIC COMPOUNDS KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-07-09 US disclosed
EP-1988091-A1 TRICYCLIC COMPOUNDS Kyowa Hakko Kogyo Co., Ltd (JP) 2008-11-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176760-A1 TRICYCLIC COMPOUNDS PPARG, PPARD, PPARA KDM4C 1453/4885GRM5 788/4885SYK 3396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.